1. Home
  2. PDSB vs DHAI Comparison

PDSB vs DHAI Comparison

Compare PDSB & DHAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDSB
  • DHAI
  • Stock Information
  • Founded
  • PDSB 2005
  • DHAI 2007
  • Country
  • PDSB United States
  • DHAI United States
  • Employees
  • PDSB N/A
  • DHAI N/A
  • Industry
  • PDSB Biotechnology: Pharmaceutical Preparations
  • DHAI
  • Sector
  • PDSB Health Care
  • DHAI
  • Exchange
  • PDSB Nasdaq
  • DHAI NYSE
  • Market Cap
  • PDSB 58.7M
  • DHAI 49.1M
  • IPO Year
  • PDSB N/A
  • DHAI N/A
  • Fundamental
  • Price
  • PDSB $0.96
  • DHAI $0.19
  • Analyst Decision
  • PDSB Strong Buy
  • DHAI
  • Analyst Count
  • PDSB 3
  • DHAI 0
  • Target Price
  • PDSB $10.00
  • DHAI N/A
  • AVG Volume (30 Days)
  • PDSB 795.8K
  • DHAI 509.9K
  • Earning Date
  • PDSB 05-14-2025
  • DHAI 02-14-2025
  • Dividend Yield
  • PDSB N/A
  • DHAI N/A
  • EPS Growth
  • PDSB N/A
  • DHAI N/A
  • EPS
  • PDSB N/A
  • DHAI N/A
  • Revenue
  • PDSB N/A
  • DHAI $69,573,000.00
  • Revenue This Year
  • PDSB N/A
  • DHAI N/A
  • Revenue Next Year
  • PDSB N/A
  • DHAI N/A
  • P/E Ratio
  • PDSB N/A
  • DHAI N/A
  • Revenue Growth
  • PDSB N/A
  • DHAI 5.40
  • 52 Week Low
  • PDSB $1.05
  • DHAI $0.19
  • 52 Week High
  • PDSB $4.42
  • DHAI $3.67
  • Technical
  • Relative Strength Index (RSI)
  • PDSB 32.49
  • DHAI 27.49
  • Support Level
  • PDSB $1.19
  • DHAI $0.24
  • Resistance Level
  • PDSB $1.41
  • DHAI $0.28
  • Average True Range (ATR)
  • PDSB 0.10
  • DHAI 0.04
  • MACD
  • PDSB -0.03
  • DHAI 0.01
  • Stochastic Oscillator
  • PDSB 2.11
  • DHAI 5.66

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About DHAI DIH HOLDINGS US INC

DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Its products Armeo Power, Armeo Spring, Armeo Spring Pro, etc.

Share on Social Networks: